Human cytomegalovirus infection and cognitive decline: insights from population and experimental studies
<i>Human cytomegalovirus (HCMV)</i>, a ubiquitous DNA betaherpesvirus, is capable of persistent infection and immunomodulation, particularly in immunocompromised and elderly hosts. Emerging evidence links HCMV to neurodegenerative diseases through its multifaceted immunomodulatory effects. This review summarizes key viral architectures and mechanisms, epidemiological trends, and experimental data supporting HCMV's role in cognitive decline. We advocate for targeted antiviral strategies and vaccine development to clarify its contribution to neurodegeneration.
Authors
- Cecilia Söderberg‐Nauclér (ORCID: https://orcid.org/0000-0001-8955-3610)
- Koon-Chu Yaiw (ORCID: https://orcid.org/0000-0001-5329-1815)
- Dorota Religa
Institutions
- Karolinska University Hospital (SE)
- University of Turku (FI)
- Karolinska Institutet (SE)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Frontiers in Aging Neuroscience
- Published
- 2026-01-20
- DOI
- https://doi.org/10.3389/fnagi.2025.1757461
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Lundbeckfonden
- Karolinska Institutet
- Päivikki ja Sakari Sohlbergin Säätiö
- Sigrid Juséliuksen Säätiö
- H. Lundbeck A/S
- Medical Research Council